Michael K. Gibson
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| pBI-11 & TA-HPV (With Pembrolizumab as Treatment for Patients w/Advanced, PD-L1 CPS≥1, hrHPV+ Oropharyngeal Cancer (NCT05799144) | Michael K. Gibson | 2023-07-26 |
Track Michael K. Gibson automatically
Every clearance here is in the API, with alerts when new ones post.